Reuters logo
3 months ago
BRIEF-Array BioPharma and Bristol-Myers Squibb announce strategic collaboration
May 30, 2017 / 11:11 AM / 3 months ago

BRIEF-Array BioPharma and Bristol-Myers Squibb announce strategic collaboration

May 30 (Reuters) - Array BioPharma Inc

* Array bioPharma and Bristol-Myers Squibb announce strategic collaboration

* Bristol-Myers Squibb Co says under terms of agreement, Array and Bristol-Myers Squibb will jointly support study with Array acting as sponsor

* Bristol-Myers Squibb Co - Collaboration to investigate safety, tolerability and efficacy of Array's investigational MEK inhibitor, binimetinib

* Bristol-Myers Squibb Co says phase 1/2 study is expected to establish recommended dose regimens for further study

* Bristol-Myers Squibb Co says results from phase 1/2 study, which is anticipated to begin in second half of 2017

* Bristol-Myers Squibb Co - Collaboration to investigate binimetinib with co's opdivo (nivolumab) and opdivo + yervoy (ipilimumab) regimen

* Bristol-Myers Squibb Co - Collaboration for potential treatment for metastatic colorectal cancer in patients with microsatellite stable tumors Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below